title: CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?
authors.affiliation: Department of Internal Medicine, V. Cervello Hospital, via Trabuco 180, 90146 Palermo, Italy. smadonia@libero.it
authors.forename: Salvatore
authors.initials: S
authors.lastname: Madonia
authors.forename: Emma
authors.initials: E
authors.lastname: Aragona
authors.forename: Simonetta
authors.initials: S
authors.lastname: Maisano
authors.forename: Luigi
authors.initials: L
authors.lastname: Montalbano
authors.forename: Mirko
authors.initials: M
authors.lastname: Olivo
authors.forename: Francesca
authors.initials: F
authors.lastname: Rossi
authors.forename: Gaetano
authors.initials: G
authors.lastname: Restivo
authors.forename: Mario
authors.initials: M
authors.lastname: Cottone
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001661:Biliary Tract Neoplasms / Q000175:diagnosis*; D018395:CA-19-9 Antigen / Q000097:blood*; D002779:Cholestasis / Q000097:blood; D003937:Diagnosis, Differential; D005189:False Positive Reactions; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000175:diagnosis*
chemical_list: D018395:CA-19-9 Antigen